Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 203.50
+0.50 (0.25%)
Jul 28, 2025, 4:35 PM GMT+1
AIM:AMS Revenue
In the year 2024, Advanced Medical Solutions Group had annual revenue of 177.52M GBP with 40.66% growth. Advanced Medical Solutions Group had revenue of 109.54M in the half year ending December 31, 2024, with 65.90% growth.
Revenue
177.52M
Revenue Growth
+40.66%
P/S Ratio
2.46
Revenue / Employee
110.95K
Employees
1,600
Market Cap
437.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 177.52M | 51.31M | 40.66% |
| Dec 31, 2023 | 126.21M | 1.88M | 1.51% |
| Dec 31, 2022 | 124.33M | 15.73M | 14.48% |
| Dec 31, 2021 | 108.60M | 21.81M | 25.12% |
| Dec 31, 2020 | 86.80M | -15.57M | -15.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |